DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-12293-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Sumit Mallick. Beteiligte Einrichtung: Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to be University), Mangalore, 57…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Proto-Oncogene Proteins, Hematopoiesis, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) is an autoimmune disorder characterized by insulin deficiency and hyperglycemia, driven by environmental insults and epigenetic reprogramming beyond genetic predisposition. Recent evidence suggests that systemic epigenetic dysregulation in T1D influences the differentiation of hematopoietic stem cells (HSCs) towards pro-inflammatory myeloid subsets, such as macrophages and dendritic cells, and compromises lymphoid tolerance, including Treg dysfunction. Mechanistically, perturbations in mitochondrial metabolism in HSCs disrupt the α-ketoglutarate/succinate ratio, which directly regulates TET dioxygenases and DNMTs. Concurrently, dysregulated DNA methylation, histone marks (e.g., H3K27me3), and noncoding RNAs (e.g., MALAT1) connect genetic risk to environmental signals. Clonal hematopoiesis (CHIP), enhanced in T1D by mutations in TET2 and DNMT3A, fuels inflammation by proliferating cytokine-excess HSC clones, thereby accelerating β-cell death. This review provides a comprehensive overview of the current research updates of the disease, including the complex network-mediated epigenetically altered T1D. Moreover, I have explored how epigenetics is involved in hematopoietic dysfunction and how epigenetic reprogramming may underpin these pathologies to mitigate T1D complications and enhance patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education & Research, Nitte (Deemed to be University), Mangalore, 575018, Karnataka, India. sumit95.zsi@gmail.com.
- Cellular Biophysics Lab, Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay, Powai, Maharashtra, 400076, India. sumit95.zsi@gmail.com.
Zitieren
APA
Mallick, S. (2026). DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12293-w
Vancouver
Mallick S. DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12293-w
BibTeX
@article{Mallick2026,
author = {Mallick, Sumit},
title = {DNMT3A/TET2-mediated epigenetic alteration in Type-1 diabetes dysregulates the haematopoiesis},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-12293-w}
}
EUVIMED